课题基金 / 基金详情

The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases

The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
损伤相关分子模式在小儿先天性心脏病围手术期发病率和死亡率中的作用
批准号:
10669290
负责人:
Koichi Yuki
金额:
$22.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-07-31
关键词:
AdultAgeBiologicalBiological AssayBirthBloodBlood PlateletsBlood TransfusionBody SizeBrainCardiac Surgery proceduresCardiopulmonary BypassCellsCessation of lifeChildChildhoodCirculationClinicalClinical ManagementCoagulation ProcessComplexDataDatabasesFailureFlow CytometryFunctional disorderGoalsHeartHeart ArrestHistonesHospital MortalityHumanImmuneImmunologicsIn VitroIncidenceIncubatedInfantInflammatoryInpatientsInterventionLigandsLive BirthLogisticsLungMediatingMedicalMitochondriaMolecularMorbidity - disease rateMusNeonatalNuclearOperative Surgical ProceduresOrganOutcomePathway interactionsPatientsPatternPattern RecognitionPattern recognition receptorPerfusionPerioperativePhysiologicalPlatelet ActivationPopulationPostoperative PeriodProductionRegional PerfusionReperfusion InjuryReporterReportingResearchRisk FactorsRodentRoleSepsisSignal PathwaySignal TransductionSourceStreamTLR2 geneTLR4 geneTestingTherapeutic InterventionThrombelastographyThrombophiliaThrombosisTimeToll-Like Receptor PathwayToll-like receptorsTraumaage groupage relatedcell injuryclinical carecongenital heart disordercytokineexperienceextracellularhigh riskhistological specimensimmune activationimprovedin vivomRNA sequencingmechanical circulatory supportmortalitymouse modelneonateneutrophilnovel therapeutic interventionorgan injuryperioperative morbidityperioperative mortalityreceptorrepairedresponsesurgery outcomesystemic inflammatory responsetherapeutic targettissue injurytissue repairtranscriptome sequencing

项目摘要

项目成果

Koichi Yuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Although the mortality of congenital heart disease (CHD) has been reduced significantly, neonates and infants undergoing cardiac surgery are still at a high risk of morbidity and mortality due to multiple organ injury/failure. In the Kids’ Inpatient Database, neonates and infants occupied about 57% of all the pediatric population undergoing congenital heart surgery and carried significantly higher in-hospital mortality rate (6.9%) compared to other age groups. Delineation of the cause and mechanism of their organ injury/dysfunction would provide an opportunity to modify our clinical approach and develop therapeutic intervention. Damage-associated molecular patterns (DAMPs) are endogenous nuclear, mitochondrial, or cytosolic molecules that have physiological functions inside the cell. However, upon tissue injury, DAMPs are released into the blood stream by injured cells, and recognized by pattern recognition receptors (PRRs) on neutrophils and platelets. DAMPs can cause organ injury by inducing systemic inflammatory responses (SIRS) and hypercoagulable state resulting in thrombosis. The circulating levels of DAMPs correlated to the SIRS and multiple organ injury in patients with trauma and sepsis. Ischemia-reperfusion injury associated with cardiopulmonary bypass (CPB) and subsequent organ injury/dysfunction has been well described. In the majority of cardiac surgical cases for older children and adults, organs other than heart and lung are continuously perfused during CPB, but in complex neonatal and infant surgery, it is not rare to have surgical repair done under complete circulatory arrest or regional perfusion only to the brain, suggesting that multiple organs may be subjected to ischemia- reperfusion injury. Blood transfusion can induce organ injury and is almost always required in neonates and infants due to their small body size relative to the volume of CPB circuit. Our preliminary study showed that the circulating levels of DAMPs interacting with Toll-like receptor (TLR)2/4/9 were elevated after CPB separation in infants and neonates. We hypothesize that 1) in congenital cardiac surgery in neonates and infants, higher DAMP levels are associated with hypercoagulability (thrombosis) as well as greater organ injury/ dysfunction, and 2) DAMPs induce more NETs-mediated thrombosis and organ injury in infants via TLRs that in adults. In Aim 1, we will examine the 1st hypothesis by performing profiling of DAMPs specific to Toll-like receptor (TLR)2, TLR4 and TLR9 and DAMPs for an aggregate of PRRs, and examine the relationship between DAMPs and systemic inflammation, neutrophil signature, coagulation, as well as postoperative outcomes of neonates and infants undergoing surgical repair. In Aim 2, we will test the 2nd hypothesis using human blood in vitro as well as in vivo mouse model. The goals of this proposal are to 1) establish the correlation between the type and levels of DAMPs and postoperative organ dysfunction/ outcomes, and 2) to determine responses to DAMPs including TLR2/4/9 functions in young age. Once we establish the correlation, we will plan to apply an intervention to reduce DAMP loads or therapeutically target responsible PRRs to mitigate organ injury.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
CD11c as a novel target to improve neutrophil effector functions and sepsis outcome
  • 批准号:
    10552923
  • 项目类别:
  • 资助金额:
    $38.94万
  • 财政年份:
    2023
  • 负责人:
    Koichi Yuki
  • 依托单位:
The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
  • 批准号:
    10492851
  • 项目类别:
  • 资助金额:
    $26.55万
  • 财政年份:
    2022
  • 负责人:
    Koichi Yuki
  • 依托单位:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
  • 批准号:
    10181647
  • 项目类别:
  • 资助金额:
    $26.55万
  • 财政年份:
    2021
  • 负责人:
    Koichi Yuki
  • 依托单位:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
  • 批准号:
    10341229
  • 项目类别:
  • 资助金额:
    $22.13万
  • 财政年份:
    2021
  • 负责人:
    Koichi Yuki
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: